Name: UMIN ID:
Unique ID issued by UMIN | UMIN000000929 |
---|---|
Receipt number | R000001100 |
Scientific Title | Randomized phase II/III study of R-CHOP versus weekly rituximab plus CHOP for CD20 positive diffuse large B cell lymphoma (JCOG0601) |
Date of disclosure of the study information | 2007/12/04 |
Last modified on | 2014/12/26 10:44:02 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2007/12/04 14:16:34 | ||
2 | Update | 2009/08/11 16:37:04 | Name of person sending information Name of person sending information Division name Division name TEL |
|
3 | Update | 2009/12/04 16:45:37 | Institutions |
|
4 | Update | 2009/12/04 16:45:56 | Recruitment status |
|
5 | Update | 2012/05/07 18:21:19 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
6 | Update | 2013/10/08 18:19:09 | Last name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Address Address TEL Division name Institutions |
|
7 | Update | 2013/10/08 18:20:00 | Last follow-up date |
|
8 | Update | 2013/10/08 18:22:24 | Anticipated trial start date Last follow-up date |
|
9 | Update | 2014/01/20 18:14:37 | Public title Public title Acronym Acronym |
|
10 | Update | 2014/01/20 18:17:29 | Condition Narrative objectives1 Narrative objectives1 |
|
11 | Update | 2014/01/20 18:20:50 | Interventions/Control_2 Key inclusion criteria Key inclusion criteria Target sample size |
|
12 | Update | 2014/01/20 19:36:22 | Condition |
|
13 | Update | 2014/12/08 11:04:19 | Recruitment status |
|
14 | Update | 2014/12/26 10:42:04 | Key inclusion criteria Key inclusion criteria |
|
15 | Update | 2014/12/26 10:44:02 | Division name Division name Division name Institutions |